Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Advance Pharmaceutical Inc. for the product Senna-s (NDC 17714-124). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient, purpose, uses, do not use, ask a doctor before use if you have, stop use and ask a doctor if, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Senna Tablets- 8.6 mg
Docusate Sodium- 50 mg
Senna Tablets- 8.6 mg ..........Laxative
Docusate Sodium- 50 mg........Stool softner
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
take preferably at bedtime or as directed by a doctor
carnuba wax, croscarmellose sodium, colloidal silicon dioxide, dicalcium phosphate, D&C Yellow # 10, FD&C Yellow # 6, hypromellose, microcrystalline cellulose, magnesium stearate, polyethylene glycol, stearic acid, titanium dioxide
call 631-981-4600, 8.30 am-4.30 pm ET, Monday - Friday
TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING
NDC- 17714-124-10
Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg
* Please review the disclaimer below.